학술논문

Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study
Document Type
Article
Source
In Clinical Gastroenterology and Hepatology September 2023 21(10):2616-2628
Subject
Language
ISSN
1542-3565